The Cyclospora Diagnostic Testing Market size is estimated to reach $2.6 billion by 2027, growing at a CAGR of 7.4% during the forecast period 2022-2027. The growth of the Cyclospora Diagnostic Testing Market is greatly fuelled by the augmenting awareness regarding Cyclospora infections and declining global hygiene standards and water supply. Awareness is spreading regarding the symptoms and risk factors pertaining to cyclospora infections like cyclosporiasis. This will probably boost the demand for diagnostic tests for cyclospora infections in the forthcoming years. Global hygiene standards and water supply are diminishing daily. With the populace growing amidst serious freshwater scarcity and heightening demand for potable water, the increasing predominance of waterborne ailments is propelling the growth of the Cyclospora Diagnostic Testing Market. Modified acid-fast staining and safranin staining techniques may be applied to oocysts. Cyclospora Diagnostic Testing may be applied in hospitals, public health labs, physician offices and Commercial/ Private Laboratories.

Cyclospora Diagnostic Testing Market Growth Drivers:

Surging Applications of Acid-fast Staining and Safranin Staining are Driving the Growth of the Cyclospora Diagnostic Testing Market:

Acid-fast staining is an accelerated and cheap staining technique principally utilized to detect Mycobacteria. Mycobacteria bring about numerous ailments in human beings like tuberculosis, leprosy and infections of the respiratory tract. Mycobacteria stained utilizing the Ziehl-Neelsen (ZN) stain are best viewed under a high-power lens (x800-1000). Cyclospora infection is diagnosed by inspecting stool specimens. The laboratory needs to utilize sensitive recovery techniques (concentration procedures) and detection techniques that feature Cyclospora oocysts. The oocysts may be stained with changed acid-fast or changed safranin methods. The surging applications of Acid-fast Staining and Safranin Staining are therefore driving the growth of the Cyclospora Diagnostic Testing Market.

Increasing Awareness of Commercial/ Private Laboratories Performing Cyclospora Testing is Propelling the Growth of the Cyclospora Diagnostic Testing Industry:

Cyclospora cayetanensis is the pathogenic species of Cyclospora and a microscopic parasite bringing about cyclosporiasis. It may take 2 days to 2 weeks to establish and may last numerous weeks to a month, if not longer. Commercial/ Private Laboratories play a vital role in cyclospora diagnosis apart from hospitals. Hospitals employ highly skilled health professionals. Microbac is one of the few laboratories with an accredited technique based on FDA guidance. Microbac is contacted to examine testing requirements and establish an account. The sample is submitted to the regional laboratory by cold chain, only after the account is set up. The sample is processed and analysis is run which aims DNA of Cyclospora. Once testing is finished and data & controls inspected, the client accepts a certificate of analysis with outcomes. The increasing awareness of Commercial/ Private Laboratories performing cyclospora testing is therefore propelling the growth of the Cyclospora Diagnostic Testing industry, thereby contributing to the Cyclospora Diagnostic Testing industry Outlook.

Novel Test Launch:

In October 2022, Thermo Fisher Scientific introduced a novel test for most typical GI Bacteria. The CE-IVD marked TaqPath Enteric Bacterial Select Panel currently introduced, detects typical gastrointestinal (GI) bacteria.

Cyclospora Diagnostic Testing Market: Competitive Landscape

Key companies holding major shares in the Cyclospora Diagnostic Testing Market are Thermo Fisher Scientific Inc., Beckman Coulter Inc., bioMerieux, Inc., CEPHEID, Diamedix Corporation, Hologic, Inc., Nanogen, Inc., Ortho Clinical Diagnostics (a Johnson & Johnson company), DiaSorin S.p.A. and Roche Diagnostics (a division of Hoffmann-La Roche).

To request for a quote, provide your details in the below link:

Media Contact:

Mr. Venkat Reddy
Sales Manager
Contact Sales: +1-970-236-3677

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.